• Division of Pancreatic Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
PENG Bing, Email: pengbing84@hotmail.com
Export PDF Favorites Scan Get Citation

Radical surgical resection is still the only potentially curative treatment for pancreatic cancer. With the update of minimally invasive concepts, the laparoscopic and robotic platform has been introduced to pancreatic surgery practice. The recent studies have demonstrated that minimally invasive procedure achieved similar or improved perioperative outcomes compared to the standard open approach. Neo-adjuvant chemotherapy is increasingly being applied in pancreatic surgery, making surgical resection more challenging. Numbers of patients undergoing minimally invasive resection following neo-adjuvant chemotherapy remain low. The author consulted the latest literatures at home and abroad and described the current situation of minimally invasive treatment of pancreatic cancer after neo-adjuvant chemotherapy.

Citation: MENG Lingwei, WU Zhong, PENG Bing. Minimally invasive treatment of pancreatic cancer following neo-adjuvant chemotherapy. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2023, 30(9): 1025-1029. doi: 10.7507/1007-9424.202308003 Copy

  • Previous Article

    第四届安贞心脏瓣膜介入治疗新技术高峰论坛暨心脏全瓣膜介入技术Workshop培训工坊会议纪要
  • Next Article

    The progress and major challenges of immunotherapy for pancreatic cancer